Compare PBLS & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBLS | LMND |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.2B |
| IPO Year | 2026 | 2020 |
| Metric | PBLS | LMND |
|---|---|---|
| Price | $32.74 | $43.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $70.86 |
| AVG Volume (30 Days) | 704.8K | ★ 962.7K |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.40 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $737,900,000.00 |
| Revenue This Year | N/A | $65.20 |
| Revenue Next Year | N/A | $33.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.15 |
| 52 Week Low | $25.56 | $43.28 |
| 52 Week High | $42.49 | $99.90 |
| Indicator | PBLS | LMND |
|---|---|---|
| Relative Strength Index (RSI) | 39.32 | 30.00 |
| Support Level | $26.42 | N/A |
| Resistance Level | $33.65 | $56.71 |
| Average True Range (ATR) | 3.14 | 1.92 |
| MACD | -0.93 | -0.42 |
| Stochastic Oscillator | 21.56 | 1.56 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.